Arno Therapeutics, Inc.

Arno Therapeutics, Inc. (Arno Therapeutics) is a bio pharmaceutical company engaged in the development of innovative products for the treatment of cancer. The company focuses on acquiring the rights to pre-clinical and early stage oncology products from various academic and research institutions and develop them for commercial use. The company currently focuses on developing its portfolio of pipeline products, which includes: AR-67, AR-12 and AR-42. In June 2008, the company was acquired by Laurier International, Inc. In May, Arno Therapeutics voluntarily filed a Form 15 with the Securities and Exchange Commission (SEC) for deregistering its common stock under the Securities and Exchange Act of 1934. The company is headquartered in New Jersey, the US.

Street: 
30 Two Bridges Road
City: 
Fairfield
Postcode: 
07004
Federal State : 
United States
WebSite: 
www.arnotherapeutics.com
Fax: 
1-973-2275759

Company Index Score

Current Index Score Historical Index Score
  • Arno Therapeutics, Inc. currently scores 50 % in the index.
  • Arno Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Arno Therapeutics, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets